Gastrointestinal neuroendocrine tumors.
نویسنده
چکیده
Gastrointestinal neuroendocrine tumors (GI-NETs) are a genetically diverse group of malignancies that sometimes produce peptides causing characteristic hormonal syndromes. NETs can be clinically symptomatic (functioning) or silent (non-functioning); both types frequently synthesize more than one peptide, although often these are not associated with specific syndromes. Based on data from various sources the incidence and prevalence of GI-NETs is increasing. Surgery is the only possible curative approach and so represents the traditional first-line therapy. However, as most patients with NETs are diagnosed once metastases have occurred, curative surgery is generally not possible. Patients therefore require medical management with the aim of relieving symptoms and suppressing tumor growth and spread. Somatostatin analogues can improve the symptoms of carcinoid syndrome and stabilize tumor growth (PROMID study) in many patients. An antiproliferative effect can also be achieved with the m-TOR inhibitor everolimus, alone or in combination with octreotide LAR. The vascular endothelial growth factor inhibitor sunitinib has demonstrated antitumor effects in pancreatic NETs. Pasireotide, the multi-receptor targeted somatostatin analogue, has the potential to be an effective therapy for de novo or octreotide-refractory carcinoid syndrome. Peptide receptor radiotherapy with yttrium 90-DOTATOC or lutetium 177-DOTATE are also new interesting treatment options for NETs.
منابع مشابه
Current Perspective on the Pathogenesis of Small Intestinal Neuroendocrine Tumors: Progress in Biomarkers and Molecular Events.
BACKGROUND Neuroendocrine tumors of the gastrointestinal tract differ in their histopathologic and clinical presentation. Small intestinal neuroendocrine tumors (SI-NETs), representing only a small portion within gastrointestinal malignancies, are often associated with a delayed diagnosis due to their non-specific symptoms. The increased incidence of SI-NETs during the last decades demands earl...
متن کاملThe role of endoscopy and endoscopic ultrasonography in the diagnosis of gastrointestinal neuroendocrine tumors
Gastrointestinal neuroendocrine tumors are rare malignancies that have been classified by the peptides they secrete and the resulting clinical symptoms. They constitute less than 2% of all gastrointestinal cancers. The gastrointestinal endocrine cells are characterized by similar cytochemical and ultrastructural characteristics. More than 30 gut hormone genes and other bioactive peptides have b...
متن کاملDiagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors
Upper gastrointestinal neuroendocrine tumors (NETs) are rare tumors which are increasingly recognised by practising endoscopists. After confirmation by endoscopic biopsies of these focal lesions, many questions may arise. As NETs are less frequently encountered compared to other malignancies or gastrointestinal pathology, many endoscopists may not fully understand the natural history, diagnosis...
متن کاملمعرفی یک مورد بیمار مبتلا به کارسینوم نورواندوکرین نازوفارنکس
Introduction: Neuroendocrine carcinoma is one of the neoplasms of neuroendocrine system which involves organs sparing of APUD cells. The most common sites of this carcinoma are gastrointestinal and pulmonary system. From a histologic standpoint, these tumors are reactive to silver stains and specific markers like NSE(Neuron Specific Enolase), synaptophysin, and chromogranin A. Case Report: ...
متن کاملA Very Rare Case Report of Neuroendocrine Tumor of the Inguinal Node
Background & Aim: Endocrine tumors are amongst the neoplasms with low prevalence that are found most often in the gastrointestinal tract, breast, and infrequently in the lymph nodes of the inguinal region. Case report: In this report a 42-years woman who referred to a doctor with a chief complaint about the presence of a mass in the right thigh. The mass was removed by surgery and after being ...
متن کاملGastroenteropancreatic neuroendocrine tumors: hormonal treatment updates.
Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of carcinomas that remain difficult to treat with conventional cytotoxic regimens. The 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium brought us new insights into the management of gastroenteropancreatic neuroendocrine tumors. The focus of this review will serve to highlight specific Abs...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of oncology : official journal of the European Society for Medical Oncology
دوره 21 Suppl 7 شماره
صفحات -
تاریخ انتشار 2010